XML 39 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Business, Basis Of Presentation And Significant Accounting Policies - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Nature Of Operations [Line Items]          
Deferred tax asset $ 1,201   $ 1,201   $ 1,201
Income tax expense 94 $ (1,664) 674 $ 269  
Retained earnings (136,386)   (136,386)   (109,165)
Total assets 417,848   417,848   463,989
Net Income (Loss) $ (820) $ (1,299) $ (27,221) $ (9,315)  
Restatement [Member]          
Nature Of Operations [Line Items]          
Deferred tax asset         (3,000)
Income tax expense         3,000
Retained earnings         (3,000)
Total assets         (3,000)
Net Income (Loss)         $ (3,000)
Rose LifeScience Inc. [Member]          
Nature Of Operations [Line Items]          
Equity ownership percentage 80.00%   80.00%